These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 2826498

  • 41. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW.
    Biochim Biophys Acta; 1977 Aug 25; 499(1):48-60. PubMed ID: 196670
    [Abstract] [Full Text] [Related]

  • 42. Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.
    Beretz A, Briançon-Scheid F, Stierlé A, Corre G, Anton R, Cazenave JP.
    Biochem Pharmacol; 1986 Jan 15; 35(2):257-62. PubMed ID: 3002388
    [Abstract] [Full Text] [Related]

  • 43. [Effect of endotoxin on aggregation and release of human platelet in vitro].
    He K, Liou HQ.
    Sheng Li Xue Bao; 1990 Dec 15; 42(6):591-4. PubMed ID: 1963501
    [Abstract] [Full Text] [Related]

  • 44. In vitro interaction between cultured cells and human blood platelets.
    Holme R, Oftebro R, Hovig T.
    Thromb Haemost; 1978 Aug 31; 40(1):89-102. PubMed ID: 725854
    [Abstract] [Full Text] [Related]

  • 45. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
    Mills DC, Smith JB.
    Biochem J; 1971 Jan 31; 121(2):185-96. PubMed ID: 4330088
    [Abstract] [Full Text] [Related]

  • 46. [Mechanisms of platelet aggregation inhibition caused by sulfonylurea compounds. 4. Discussion, summary, and literature].
    Losert VW, Scholz C, Hoder A.
    Arzneimittelforschung; 1975 Apr 31; 25(4):547-60. PubMed ID: 168907
    [Abstract] [Full Text] [Related]

  • 47. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
    Zahavi M, Zahavi J, Kakkar VV.
    Life Sci; 1984 Oct 01; 35(14):1497-503. PubMed ID: 6090838
    [Abstract] [Full Text] [Related]

  • 48. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
    Palma-Barqueros V, Torregrosa JM, Caparrós-Pérez E, Mota-Pérez N, Bohdan N, Llanos MDC, Begonja AJ, Sola-Visner M, Vicente V, Teruel-Montoya R, Rivera J, Ferrer-Marín F.
    Neonatology; 2020 Oct 01; 117(1):15-23. PubMed ID: 31786577
    [Abstract] [Full Text] [Related]

  • 49. Thymosin-induced human serum factor increasing cyclic AMP.
    Astaldi A, Astaldi GC, Wijermans P, Groenewoud M, Schellekens PT, Eijsvoogel VP.
    J Immunol; 1977 Sep 01; 119(3):1106-8. PubMed ID: 197166
    [Abstract] [Full Text] [Related]

  • 50. Effects of protopine on blood platelet aggregation. II. Effect on metabolic system of adenosine 3',5'-cyclic monophosphate in platelets.
    Shiomoto H, Matsuda H, Kubo M.
    Chem Pharm Bull (Tokyo); 1990 Aug 01; 38(8):2320-2. PubMed ID: 2177684
    [Abstract] [Full Text] [Related]

  • 51. Platelet aggregation inhibitors. II - N-heterocyclic aldoxime methiodides (1).
    Antonini I, Franchetti P, Grifantini M, Gulini U, Martelli S, Petrelli F.
    Farmaco Sci; 1976 Nov 01; 31(11):809-16. PubMed ID: 1010032
    [Abstract] [Full Text] [Related]

  • 52. Thrombin decreases platelet cyclic AMP in the absence of prostaglandin synthesis.
    Lagarde M, Dechavanne M.
    Biomedicine; 1977 Apr 01; 27(3):110-2. PubMed ID: 196696
    [Abstract] [Full Text] [Related]

  • 53. The disappearance of adenosine from blood and platelet suspension in relation to the platelet cyclic AMP content.
    Söderbäck U, Sollevi A, Fredholm BB.
    Acta Physiol Scand; 1987 Feb 01; 129(2):189-94. PubMed ID: 3033995
    [Abstract] [Full Text] [Related]

  • 54. Thrombin-induced platelet prostaglandin and cyclic AMP production and a possible intrinsic modulation of platelet function.
    Droller MJ.
    Scand J Haematol; 1976 Sep 01; 17(3):167-78. PubMed ID: 184521
    [Abstract] [Full Text] [Related]

  • 55. Relation between the inhibition of aggregation and the concentration of cAMP in human and rat platelets.
    Michel H, Caen JP, Born GV, Miller R, D'Auriac GA, Meyer P.
    Br J Haematol; 1976 May 01; 33(1):27-38. PubMed ID: 178342
    [Abstract] [Full Text] [Related]

  • 56. The effect of ADP, calcium and some inhibitors of platelet aggregation on protein phosphokinases from human blood platelets.
    Bishop GA, Rozenberg MC.
    Biochim Biophys Acta; 1975 Mar 28; 384(1):112-9. PubMed ID: 165830
    [Abstract] [Full Text] [Related]

  • 57. Mechanism of action of the platelet function inhibitor from Vipera russelli siamensis snake venom.
    Li YS, Liu KF, Wang QC.
    Toxicon; 1986 Mar 28; 24(9):875-83. PubMed ID: 3027921
    [Abstract] [Full Text] [Related]

  • 58. Investigation of the effects of phospholipase C on human platelets: evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP.
    Akbar H, Navran SS, Chang J, Miller DD, Feller DR.
    Thromb Res; 1982 Aug 15; 27(4):405-17. PubMed ID: 6293114
    [Abstract] [Full Text] [Related]

  • 59. Effect of heparin and heparin fractions on platelet aggregation.
    Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L.
    J Clin Invest; 1980 Jan 15; 65(1):64-73. PubMed ID: 6243142
    [Abstract] [Full Text] [Related]

  • 60. Effect of forskolin on platelet deaggregation and cyclic AMP generation.
    Kariya T, Morito F, Sakai T, Takahata K, Yamanaka M.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct 15; 331(1):119-21. PubMed ID: 2999615
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.